These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3060147)

  • 21. Variants of human seminal acrosin inhibitor (HUSI-II) which inhibit human leukocyte elastase.
    Collins J; Taube W; Fink E; Möritz A; Fritz H
    Biomed Biochim Acta; 1991; 50(4-6):683-5. PubMed ID: 1801743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
    Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H
    Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human neutrophil elastase inhibitors in innate and adaptive immunity.
    Fitch PM; Roghanian A; Howie SE; Sallenave JM
    Biochem Soc Trans; 2006 Apr; 34(Pt 2):279-82. PubMed ID: 16545094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cleaved SLPI, a novel biomarker of chymase activity.
    Belkowski SM; Masucci J; Mahan A; Kervinen J; Olson M; de Garavilla L; D'Andrea MR
    Biol Chem; 2008 Sep; 389(9):1219-24. PubMed ID: 18713008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and characterization of recombinant second domain variants of human mucus proteinase inhibitor (MPI).
    Meckelein B; Kemme M; Nikiforov T; Appelhans H; Gassen HG
    Biomed Biochim Acta; 1991; 50(4-6):673-6. PubMed ID: 1801741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel distribution of the secretory leucocyte proteinase inhibitor in kidney.
    Ohlsson S; Ljungkrantz I; Ohlsson K; Segelmark M; Wieslander J
    Mediators Inflamm; 2001 Dec; 10(6):347-50. PubMed ID: 11817677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester.
    Maruyama M; Hay JG; Yoshimura K; Chu CS; Crystal RG
    J Clin Invest; 1994 Jul; 94(1):368-75. PubMed ID: 7913712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of human kallikrein 7 (hK7/SCCE) and its inhibitor antileukoprotease (ALP/SLPI) in uterine endocervical glands and in cervical adenocarcinomas.
    Tian X; Shigemasa K; Hirata E; Gu L; Uebaba Y; Nagai N; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Nov; 12(5):1001-6. PubMed ID: 15492784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An elastase-specific inhibitor from human bronchial mucus. Isolation and characterization.
    Hochstrasser K; Albrecht GJ; Schönberger OL; Rasche B; Lempart K
    Hoppe Seylers Z Physiol Chem; 1981 Oct; 362(10):1369-75. PubMed ID: 6914299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle.
    Moriyama A; Shimoya K; Ogata I; Kimura T; Nakamura T; Wada H; Ohashi K; Azuma C; Saji F; Murata Y
    Mol Hum Reprod; 1999 Jul; 5(7):656-61. PubMed ID: 10381821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and distribution of recombinant secretory leukocyte proteinase inhibitor in rats.
    Gast A; Anderson W; Probst A; Nick H; Thompson RC; Eisenberg SP; Schnebli H
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):889-94. PubMed ID: 2327652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of the secretory leukocyte protease inhibitor on leukocyte proteases released during phagocytosis.
    Axelsson L; Linder C; Ohlsson K; Rosengren M
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():89-93. PubMed ID: 2578013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secretory leukocyte protease inhibitor in the cervical mucus and in the fetal membranes.
    Helmig R; Uldbjerg N; Ohlsson K
    Eur J Obstet Gynecol Reprod Biol; 1995 Mar; 59(1):95-101. PubMed ID: 7781866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential inhibition of mast cell chymases by secretory leukocyte protease inhibitor.
    Pemberton AD; Huntley JF; Miller HR
    Biochim Biophys Acta; 1998 Jan; 1379(1):29-34. PubMed ID: 9468329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Location of the protease-inhibitory region of secretory leukocyte protease inhibitor.
    Eisenberg SP; Hale KK; Heimdal P; Thompson RC
    J Biol Chem; 1990 May; 265(14):7976-81. PubMed ID: 2110563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of proteinase 3 activity by peptides derived from human epidermis.
    Wiedow O; Lüdemann J; Utecht B; Christophers E
    Adv Exp Med Biol; 1993; 336():61-4. PubMed ID: 8296675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophil elastase increases secretory leukocyte protease inhibitor transcript levels in airway epithelial cells.
    Abbinante-Nissen JM; Simpson LG; Leikauf GD
    Am J Physiol; 1993 Sep; 265(3 Pt 1):L286-92. PubMed ID: 8105697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitors of elastase in airway lavage samples from ventilated preterm human neonates.
    Griese M; Pudenz P; Gebhard W
    Am J Respir Crit Care Med; 1998 Jul; 158(1):256-62. PubMed ID: 9655738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of mast cell chymase by eglin c and antileukoprotease (HUSI-I). Indications for potential biological functions of these inhibitors.
    Fink E; Nettelbeck R; Fritz H
    Biol Chem Hoppe Seyler; 1986 Jul; 367(7):567-71. PubMed ID: 3530282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secretory leukocyte protease inhibitor, but not alpha-1 protease inhibitor, blocks tryptase-induced bronchoconstriction.
    Forteza RM; Ahmed A; Lee T; Abraham WM
    Pulm Pharmacol Ther; 2001; 14(2):107-10. PubMed ID: 11273791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.